Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer

Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer

A large body of clinical and experimental evidence indicates that colorectal cancer is one of the most common multifactorial diseases. Although some useful prognostic biomarkers for clinical therapy have already been identified, it is still difficult to characterize a therapeutic signature that is a...

Full description

Bibliographic Details
Main Authors: Mariarosaria Conte, Annabella Di Mauro, Lucia Capasso, Liliana Montella, Mariacarla De Simone, Angela Nebbioso, Lucia Altucci
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
epigenetics
colorectal cancer
immune infiltrates
patient
mutation
genetic/epigenetic/immunological signature
Online Access:https://www.mdpi.com/2072-6694/15/7/1960

Similar Items

Similar Items